|
Plasmid for Respiratory Syncytial Virus (RSV) Vaccine Development & Research
Applications
Bacterial artificial chromosome (BAC) plasmid containing the antigenomic sequence A2-BAG-BAF derived from multiple strains of RSV.
Key Benefits
Viral DNA is contained in a BAC, allowing for efficient mutagenesis and recombineering of viral DNA.
BAC is stable and can be used for cloning in common bacteria types like E. coli.
Provides...
Published: 7/28/2023
Contributor(s): Martin Moore, Anne Hotard (Lopez-Ona)
|
|
Recombinant Respiratory Syncytial Viruses (RSVs) Expressing the G and F Proteins from Various Strains
ApplicationRecombinant RSV Strains Expressing the G and F Proteins from various geographically distributed RSV strains for use in drug and vaccine screeningKey BenefitsProvides new and needed tool for screening potential RSV therapies, ensuring they are broadly effective against multiple, geographically distinct strains of the virus Expresses the red...
Published: 4/23/2024
Contributor(s): Martin Moore, Anne Hotard (Lopez-Ona), Christina Rostad, Barney Graham, Syed Moin
|
|
Respiratory syncytial virus (RSV) Reporter Plasmid for High Throughput Drug Screening
Application
Bioluminescence reporter for high throughput respiratory syncytial virus (RSV) drug discovery.
Key Benefits
Simple luciferase readout marker indicates RSV replication activity.
Market Summary
RSV is a ubiquitous respiratory pathogen worldwide. It is the most common cause of severe lower respiratory tract disease among infants and young...
Published: 4/23/2024
Contributor(s): Martin Moore, Anne Hotard (Lopez-Ona), Richard Plemper
|
|
Respiratory Syncytial Virus (RSV) Fluorescent Reporter Strain
Application
Modified RSV incorporating a red fluorescent reporter protein for vaccine, drug and biologic research & development.
Key Benefits
Provides new and needed screening tool for RSV research.
Fluorescent protein included has better in vivo imaging capabilities than other more commonly used fluorescent proteins.
Market Summary
RSV...
Published: 4/23/2024
Contributor(s): Martin Moore, Anne Hotard (Lopez-Ona)
|
|
Novel Tool for Respiratory Syncytial Virus (RSV) Vaccine Development & Research
Applications Bacterial artificial choromosome (BAC) plasmid containing the antigenomic sequence of RSV that can be used for directed mutations of the virus and thus vaccine generation. Key BenefitsViral DNA is contained in a BAC, Allowing for efficient mutagenesis and recombineering of viral DNA. BAC is stable, can be used for cloning in common bacteria...
Published: 4/23/2024
Contributor(s): Martin Moore, Anne Hotard (Lopez-Ona)
|